Literature DB >> 28941395

Malaria in Southern Brazil: a potential threat for a non-endemic region.

Daisson L Moreira1, Jader C Cardoso2, Sandra C Deboni3, Diego R Falci4.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28941395      PMCID: PMC9425526          DOI: 10.1016/j.bjid.2017.07.004

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   3.257


× No keyword cloud information.
Dear Editor: It is of great concern the current re-emergence of tropical diseases in non-endemic areas. Malaria is still a major health problem in many areas of Brazil, particularly in the Amazon region. Nevertheless, outside the Amazon basin cases are often unrecognized by health care workers. This lack of understanding delays diagnosis, increases lethality and probably potential for transmission (since individuals may remain parasitemic for longer periods). Rio Grande do Sul is a southern State of Brazil where autochthonous cases of Malaria have not occurred since 1968. A significant parcel of its territory is located inside the Atlantic Forest, where the bromeliad mosquito Anopheles (Kerteszia) cruzii, an effective Malaria vector, is present, therefore increasing the potential for resurgent of autochthonous cases, with unpredictable consequences. Data from the Information System for Notifiable Diseases (SINAN) were retrospectively reviewed to characterize Malaria cases reported in Rio Grande do Sul from 2007 to 2015. A total of 383 cases were notified to the system. Only imported cases were reported. Incidence of Malaria in Rio Grande do Sul varied from 0.252 in 2007 to 0.523 cases in 2015 (chi-square for trend; p = 0.78) per 100,000 inhabitants. Most cases occurred in men (318 cases; 83.0%); 47.0% were aged 20–49 years. Most frequent identified professional activity was truck driver (21.8%). Plasmodium vivax was the most frequent species (36.0%) identified in thick blood smears. Plasmodium falciparum was identified in 9.7% of positive smears. Municipalities with the highest incidence were in the central or northern regions, near the Atlantic Forest and the border with Santa Catarina State (Fig. 1). Probable states of infection were Rondonia (15.4%), Amazonas (12.5%) and Pará (5.5%). Of positive smears, 30 (17.5%) had a probable infection origin outside Brazil: most frequent countries were South Africa (26.7%), Haiti (23.3%), and Angola (13.3%); 86.4% of these cases were P. falciparum infection.
Fig. 1

Mean incidence of imported cases of malaria in Rio Grande do Sul State, period 2007–2015 (cases/100,000 inhabitants).

Mean incidence of imported cases of malaria in Rio Grande do Sul State, period 2007–2015 (cases/100,000 inhabitants). Understanding of epidemiology of Malaria is fundamental for approaching disease control. Migration and occupations requiring travel contribute to the maintenance of imported cases of Malaria in Rio Grande do Sul State. The knowledge of patients’ profile and clinical suspicion from the part of health care workers is essential to a better disease management. Even though the frequency of disease is low, a high level of awareness is necessary considering the vector presence and individuals requiring health care.

Conflicts of interest

The authors declare no conflicts of interest.
  3 in total

1.  Malaria epidemiology in the State of Piauí, Northeastern Brazil: a retrospective study with secondary data.

Authors:  Joyce Anny Alves do Nascimento; Lucas Melo Guimarães; Filipe Anibal Carvalho-Costa
Journal:  Rev Soc Bras Med Trop       Date:  2016-02       Impact factor: 1.581

2.  Spatial and temporal epidemiology of malaria in extra-Amazonian regions of Brazil.

Authors:  Camila Lorenz; Flávia Virginio; Breno S Aguiar; Lincoln Suesdek; Francisco Chiaravalloti-Neto
Journal:  Malar J       Date:  2015-10-15       Impact factor: 2.979

3.  Malaria diagnosis: still a challenge in non-endemic countries.

Authors:  Ioanna Voulgaridi; Theocharis Koufakis; Evdokia Ntava; Nikolaos Zisis; Maria Tsiakalou
Journal:  Braz J Infect Dis       Date:  2016-06-05       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.